Huaan Securities Co., Ltd. (SHA:600909)

Sage Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	2,380	1,018	1,679	2,550	2,041
Short-Term Investments	-	25,319	16,806	18,656	19,610	19,775
Trading Asset Securities	-	36,753	27,606	25,587	23,281	10,535
Accounts Receivable	-	399.78	98.87	108.09	128.23	234.31
Other Receivables	-	11,472	10,536	9,198	10,308	8,578
Property, Plant & Equipment	-	1,529	1,565	926.21	885.27	641.17
Goodwill	-	3.83	3.83	3.83	3.83	3.83
Other Intangible Assets	-	200.32	207.5	167.49	126.33	94.92
Investments in Debt & Equity Securities	-	18,011	15,256	10,705	11,098	1,688
Other Current Assets	-	3,239	3,023	3,712	2,939	9,941
Long-Term Deferred Tax Assets	-	11.76	292.68	361.48	389.06	377
Other Long-Term Assets	-	3,528	3,059	2,763	2,273	4,599
Total Assets	-	103,014	79,558	73,938	73,641	58,613
Accrued Expenses	-	24,394	16,087	17,732	18,153	16,101
Short-Term Debt	-	7,952	5,279	3,689	3,376	2,673
Current Portion of Long-Term Debt	-	24,084	17,866	16,345	15,608	9,627
Other Current Liabilities	-	2,957	2,559	2,468	4,712	4,141
Long-Term Debt	-	19,960	15,423	12,296	11,162	10,535
Long-Term Leases	-	144.92	159.47	199.32	235.64	-
Long-Term Unearned Revenue	-	14.24	41.43	41.03	37.43	22.6
Long-Term Deferred Tax Liabilities	-	312.98	326.28	265.77	272.37	209.63
Other Long-Term Liabilities	-	453.53	614.9	644.39	235.48	125.82
Total Liabilities	-	80,492	58,409	53,727	53,996	43,731
Common Stock	-	4,698	4,698	4,698	4,698	3,621
Additional Paid-In Capital	-	7,979	7,978	7,978	7,978	5,111
Retained Earnings	-	8,930	7,916	7,120	6,417	5,428
Comprehensive Income & Other	-	945.06	488.93	329.98	386.05	384.82
Total Common Equity	22,840	22,451	21,081	20,125	19,479	14,545
Minority Interest	-	70.75	67.59	85.19	165.55	337.94
Shareholders' Equity	22,910	22,522	21,149	20,211	19,644	14,883
Total Liabilities & Equity	-	103,014	79,558	73,938	73,641	58,613
Total Debt	49,325	52,141	38,728	32,530	30,381	22,834
Net Cash (Debt)	14,274	12,311	6,702	13,391	15,060	9,517
Net Cash Growth	-	83.68%	-49.95%	-11.08%	58.25%	-37.96%
Net Cash Per Share	2.90	2.49	1.37	2.72	3.28	2.55
Filing Date Shares Outstanding	4,678	4,682	4,698	4,698	4,698	3,621
Total Common Shares Outstanding	4,678	4,682	4,698	4,698	4,698	3,621
Working Capital	-	20,079	17,281	18,685	16,762	18,320
Book Value Per Share	4.88	4.80	4.49	4.28	4.15	4.02
Tangible Book Value	22,638	22,247	20,870	19,954	19,349	14,446
Tangible Book Value Per Share	4.84	4.75	4.44	4.25	4.12	3.99

Updated Jan 26, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.